GrowthCap Announces The Top 25 Healthcare Investors of 2023
This year's awardees are the top healthcare investors who have demonstrated the attributes to sustain a high level of investment performance - past, present and future.
NEW YORK, May 23, 2023 /PRNewswire-PRWeb/ -- GrowthCap is pleased to announce The Top 25 Healthcare Investors of 2023. Our third year running, the healthcare awards process has become more competitive not only in the number of participants but also in the caliber of individuals put forth. We are inspired by the dedication of this year's awardees toward their craft and towards solving some of the healthcare industry's most pressing challenges. These investors have highly specialized knowledge, are keenly aware of sub-sector areas to focus on, work effectively with management teams, and operate strategically to consistently produce successful outcomes.
Over 350 firms were pre-qualified to participate in this year's process and in many cases, several investors were nominated from a given firm. To determine the awardees, we placed considerable weight on feedback received from portfolio company CEOs, firm colleagues and peers in the industry. We also conducted our own proprietary research. The overarching goal was to determine those investors who have demonstrated the attributes to sustain a high level of investment performance - past, present and future. As we like to say, returns are a lagging indicator and attributes are a leading indicator.
Healthcare plays a critical role in the quality of our lives, underpins all other business and economic activity, and ultimately determines the state of our world.
Please join us in recognizing and celebrating the achievements of The Top 25 Healthcare Investors of 2023.
Ezra Perlman (Francisco Partners), John Schilling, MD (TPG), David Schuppan (The Vistria Group), Mark Taber (Great Hill Partners), Jeff Crisan (Silversmith Capital Partners), Darren Black (Summit Partners), Rafael Cofiño (Great Hill Partners), Jeff Haywood and Steve Lesieur (Spectrum Equity), Bradley Sloan (Questa Capital), Martin Felsenthal (Health Velocity Capital), Robert Mittendorff, MD (B Capital), Chelsea Stoner (Battery Ventures), TJ Carella (Warburg Pincus), Lonne Jaffe (Insight Partners), Zach Ferguson (TPG), Justin Chen (Francisco Partners), Aliya Khaydarova (Inverness Graham Investments), Ross Stern (Summit Partners), Laura Veroneau (Optum Ventures), Matt Emery and Sureel Sheth (JMI Equity), Matt Carroll (WestView Capital Partners), Scott Barclay (Insight Partners), Owen Davis (Martis Capital), Calen Angert (Brighton Park Capital), Brian Peterson (Silversmith Capital Partners), Dave Schulte (McKesson Ventures), Brett Shaheen (Redesign Health).
The full article can be read at https://growthcapadvisory.com/.
About GrowthCap
GrowthCap's primary focus is to aid CEOs in better understanding the universe of capital alternatives offered by institutional investors such as private equity firms, growth equity firms, venture capital and family offices. GrowthCap also aims to provide CEOs with insights into how other entrepreneurs and executives have succeeded in scaling their businesses. While emphasis has been on select sectors including business software, business services, healthcare and consumer products and services, GrowthCap is often involved in other segments of the broader economy.
Media Contact
Editor, GrowthCap, 1 6464703188, [email protected]
SOURCE GrowthCap
Share this article